Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biosimilars Will Get Regulatory Science Program, Supplement Timeline Changes In Next User Fee Agreement
Jul 13 2021
•
By
Derrick Gingery
The completed BsUFA III agreement includes supplement timeline improvements. • Source: Illustration
More from Biosimilars
More from Biosimilars & Generics